E Keppra Generics from 12 Firms to Join NHI Price List, Patanol and Velcade AGs Too

A total of 12 companies will obtain reimbursement listing for their generic versions of UCB’s mainstay epilepsy drug E Keppra (levetiracetam) on December 10, with more than half of them telling Jiho that they plan to roll out their products...read more